Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1989Journal of Biological ChemistryOpen Access

Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of β-galactosidase and the binding of β-galactosidase to purified IGF-II/mannose 6-phosphate receptor

View Full Paper
Ask AI
Bookmark
Share

Authors

CTCheryl L. ThomasTarget (United States)LGLawrence A. GreensteinNational Institutes of HealthLLL Lee

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thomas et al. (1989) studied this question.

synapsesocial.com/papers/6a8a4e991acf8e321fbd77eahttps://doi.org/10.1016/s0021-9258(18)83801-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.1988 · 190 citations
  2. 2The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay1973 · 3,268 citations
  3. 3Synthesis of Insulin-Like Growth Factor II (IGF-II) in Fetal Rat Tissues: Translation of IGF-II Ribonucleic Acid and Processing of Pre-Pro-IGF-II*1988 · 47 citations